Mirae Asset Global ETFs Holdings’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$351K Buy
5,348
+636
+13% +$47.2K ﹤0.01% 2066
2025
Q4
$372K Buy
4,712
+582
+14% +$39.7K ﹤0.01% 2035
2025
Q3
$139K Sell
4,130
-824
-17% -$20.3K ﹤0.01% 2509
2025
Q2
$70.7K Sell
4,954
-2,011
-29% -$26K ﹤0.01% 2767
2025
Q1
$97.4K Buy
6,965
+312
+5% +$4.24K ﹤0.01% 2644
2024
Q4
$102K Buy
6,653
+956
+17% +$14.6K ﹤0.01% 2684
2024
Q3
$89.2K Buy
5,697
+819
+17% +$11.5K ﹤0.01% 2760
2024
Q2
$69.1K Buy
+4,878
New +$76.2K ﹤0.01% 2699

Other funds holding INBX

Mirae Asset Global ETFs Holdings's INBX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Inhibrx (INBX) stake by 13% in Q1 2026, buying an estimated $47.2K and bringing the position to 5,348 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

Mirae Asset Global ETFs Holdings first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $372K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 5,348 shares of Inhibrx worth $351K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 636 Inhibrx shares in Q1 2026, an estimated $47.2K.
  • Inhibrx made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2066 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Inhibrx position peaked at $372K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.